Hikma Pharmaceuticals PLC 2024 Sustainability Report
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2024
Type: Sustainability Report
Pages: 53
The report describes a 2024 Double Materiality Assessment overseen by the Board, a 25% Scope 1 and 2 reduction target by 2030 from a 2020 baseline, and a workforce of 9,515 employees. It reports a 17% reduction in Scope 1 and 2 emissions since 2020, 98% employee Code of Conduct training completion, and a Scope 3 total of 860,710 tCO2e.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.